Christoph U. Correll, MD, PhD
a:3:{i:0;s:116:"Department of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Uniondale, New York";i:1;s:71:"Department of Psychiatry, Zucker Hillside Hospital, Glen Oaks, New York";i:2;s:93:"Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany";}
Review Article
Outcomes of NMS With Depot Versus Oral Antipsychotics
November 24, 2020
Is the advantage of longer-term medication release with long-acting injectable antipsychotics offset by an increased risk of more prolonged and severe neuroleptic malignant syndrome? This systematic review and pooled...
Academic Highlights
Schizophrenia Remission Roller Coaster
June 30, 2020
In this journal CME activity, find experts' recommendations for reducing schizophrenia relapse, such as adopting a patient-centered approach, selecting medications based on current evidence, and implementing psychosocial interventions.